Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Peroxitech Therapeutics
company
About
Peroxitech Therapeutics operates as a biopharmaceutical company.
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $25M
- Industries
- Biopharma,Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2016
- Operating Status
- Active
Peroxitech Therapeutics operates as a biopharmaceutical company developing PIP-2 to reverse acute lung injury (ALI) by targeting the cytokine storm cascade process.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$25M
Peroxitech Therapeutics has raised a total of
$25M
in funding over 2 rounds. Their latest funding was raised on
Dec 13, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 13, 2022 | Series A | $25M | 1 |
Xontogeny
|
— | Detail |
| May 12, 2021 | Seed | — | 1 |
Xontogeny
|
— | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
